79 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
in effect.
“FDA” means the U.S. Food and Drug Administration.
“Financial Expert” means an independent certified public accounting firm of nationally … by an independent public accounting firm selected by Parent and an independent public accounting firm selected by the Acting Holders.
“Net Cash Adjustment
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Tender offer solicitation (amended)
9:40pm
the Company Board Recommendation, the Independent Directors also considered the following factors relating to the procedural safeguards that the Independent … Directors believed were present to ensure fairness of the Offer and the Merger, each of which the Independent Directors believe supported their decision
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
.
At a meeting of the Company Board held on April 16, 2023, seven of the eight Independent Directors (who are identified below) unanimously: (i … are independent for purposes of evaluating a transaction between the Company, on the one hand, and Parent and Purchaser, on the other hand: John
10-K/A
2022 FY
STSA
Satsuma Pharmaceuticals Inc
28 Apr 23
Annual report (amended)
4:08pm
as a member of our Board since September 2017. He has served as an independent biotechnology consultant and advisor since August 2016. Mr. King served … and evaluate our business operations as needed and to
make decisions that are independent of our management. The Corporate Governance Guidelines are also
8-K
EX-10.1
asgygzm0gvfnuie uknr
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
ydt5ykk0
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
jokpabaenljkpz
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.2
m04v70l 9cmfsug7
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-1.1
guk9y6v8
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
naoftp1q6de pxzo6hu
3 Nov 22
Prospectus supplement for primary offering
4:42pm
8-K
z2xic 7yvily8lj95
7 Jun 22
Submission of Matters to a Vote of Security Holders
6:31am
DEFA14A
rpcsqq02bkkzk7 528
19 Apr 22
Additional proxy soliciting materials
5:40pm
S-8
o0jmq0 1e4wiy9j8c
16 Mar 22
Registration of securities for employees
4:25pm
S-8
EX-23.1
yel2g3u6z66enobhl
16 Mar 22
Registration of securities for employees
4:25pm